Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $86,000 | 23 | 70.5% |
| Travel and Lodging | $28,391 | 56 | 23.3% |
| Food and Beverage | $3,815 | 66 | 3.1% |
| Consulting Fee | $3,700 | 3 | 3.0% |
| Education | $9.91 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Clovis Oncology, Inc. | $84,711 | 68 | $0 (2018) |
| TESARO, Inc. | $34,002 | 40 | $0 (2018) |
| GlaxoSmithKline, LLC. | $1,412 | 5 | $0 (2024) |
| Intuitive Surgical, Inc. | $1,257 | 21 | $0 (2018) |
| Stryker Corporation | $109.63 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $91.05 | 2 | $0 (2022) |
| Novo Nordisk Inc | $89.26 | 1 | $0 (2019) |
| Puma Biotechnology, Inc. | $45.00 | 1 | $0 (2018) |
| Lilly USA, LLC | $37.15 | 1 | $0 (2018) |
| Eisai Inc. | $36.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.29 | 2 | GlaxoSmithKline, LLC. ($42.66) |
| 2023 | $36.00 | 1 | Eisai Inc. ($36.00) |
| 2022 | $128.28 | 3 | AstraZeneca Pharmaceuticals LP ($91.05) |
| 2020 | $1,332 | 3 | GlaxoSmithKline, LLC. ($1,332) |
| 2019 | $89.26 | 1 | Novo Nordisk Inc ($89.26) |
| 2018 | $51,266 | 58 | Clovis Oncology, Inc. ($44,964) |
| 2017 | $68,991 | 81 | Clovis Oncology, Inc. ($39,746) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/03/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Genetic Disease | ||||||
| 03/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $42.66 | General |
| 03/25/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $36.00 | General |
| Category: Oncology | ||||||
| 09/30/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $44.68 | General |
| Category: Oncology | ||||||
| 09/29/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $37.23 | General |
| 03/21/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $46.37 | General |
| Category: Oncology | ||||||
| 02/13/2020 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $894.80 | General |
| 02/13/2020 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $265.61 | General |
| 02/13/2020 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $171.60 | General |
| 06/20/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $89.26 | General |
| Category: Obesity | ||||||
| 10/12/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Oncology | ||||||
| 10/01/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Oncology | ||||||
| 09/27/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $736.23 | General |
| Category: Oncology | ||||||
| 09/27/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $646.60 | General |
| Category: Oncology | ||||||
| 09/27/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $175.56 | General |
| Category: Oncology | ||||||
| 09/27/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 09/17/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Oncology | ||||||
| 09/13/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $546.63 | General |
| Category: Oncology | ||||||
| 09/13/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $124.20 | General |
| Category: Oncology | ||||||
| 08/08/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Oncology | ||||||
| 08/03/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $321.27 | General |
| Category: Oncology | ||||||
| 08/02/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $866.60 | General |
| Category: Oncology | ||||||
| 08/02/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $596.64 | General |
| Category: Oncology | ||||||
| 08/02/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Travel and Lodging | In-kind items and services | $196.62 | General |
| Category: Oncology | ||||||
| 08/02/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
About Dr. Michael Method, M.D
Dr. Michael Method, M.D is a Gynecologic Oncology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437153913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Method, M.D has received a total of $121,916 in payments from pharmaceutical and medical device companies, with $73.29 received in 2024. These payments were reported across 149 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($86,000).
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Indianapolis, IN
- Active Since 06/13/2005
- Last Updated 05/03/2017
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1437153913
Products in Payments
- Rubraca (Drug) $84,711
- ZEJULA (Drug) $34,002
- Da Vinci Surgical System (Device) $1,257
- vitagel (Device) $109.63
- LYNPARZA (Drug) $91.05
- Saxenda (Drug) $89.26
- Nerlynx (Drug) $45.00
- CYRAMZA (Drug) $37.15
- Lenvima (Drug) $36.00
- FABRAZYME (Biological) $30.63
- YONDELIS (Drug) $20.53
- KEYTRUDA (Biological) $19.40
- Avastin (Biological) $14.59
- ENSEAL Product Family (Device) $14.16
- EXPAREL (Drug) $12.37
- ZYTIGA (Drug) $10.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Indianapolis
Jessica Parker Metter, Md, MD
Gynecologic Oncology — Payments: $3,788
Sarah Goodrich, Md, MD
Gynecologic Oncology — Payments: $3,397
Dr. Meenu Goel, Md, MD
Gynecologic Oncology — Payments: $3,047
Dr. David Moore, Md, MD
Gynecologic Oncology — Payments: $1,541
Miss. Megan Buechel, M.d, M.D
Gynecologic Oncology — Payments: $1,052
Zenas Chang, Md, Ms, MD, MS
Gynecologic Oncology — Payments: $775.82